factual

Vaccine Gross and Operating Margins

Moderna's COVID vaccine has cost of sales near 20% and an operating margin near 50%, placing it within normal vaccine economics while above traditional pharma margins.

factualpending

Speaker

Matthew Harrison

Evidence Quote

“Moderna has given guidance that cost of sales is about 20%... operating margin for the vaccine, which they've said is about 50%.”

Source

Moderna: The Software of Life— Business Breakdowns
Created: 11/15/2026, 7:57:10 PM

Your notes

Loading notes...